SWITZERLAND – The World Health Organization’s technical advisory group requested “additional clarifications” from Bharat Biotech on Tuesday for its COVID-19 vaccine Covaxin in order to conduct a final “risk-benefit assessment”…
Read MoreNo Emergency Use Listing approval for Covaxin yet, more clarifications needed
